M Aviram|J G Brook - JoVE Visualize

Showing results (191-200 of 255) with videos related to

Pageof 26

Sort By:

Annals of Nutrition & Metabolism|September 6, 2000

Dietary supplementation of a natural isomer mixture of beta-carotene inhibits oxidation of LDL derived from patients with diabetes mellitusY Levy, H Zaltsberg, A Ben-Amotz, et al.

Metabolism: Clinical and Experimental|January 1, 1979

Low density lipoprotein metabolism in type IV and type V hyperlipoproteinemiaJ G Brook, H Torsvik, R S Lees, et al.

Scandinavian Journal of Clinical and Laboratory Investigation|November 1, 1992

Effect of lovastatin on lipoprotein fluidity in patients with hypercholesterolaemiaY Levy, L Klein, M Aviram, et al.

Atherosclerosis|April 27, 2000

Macrophage-released proteoglycans enhance LDL aggregation: studies in aorta from apolipoprotein E-deficient miceI Maor, T Hayek, M Hirsh, et al.

Atherosclerosis|May 6, 1998

The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidationP A Belinky, M Aviram, B Fuhrman, et al.

Biochemical and Biophysical Research Communications|March 18, 2000

Oxidized monocyte-derived macrophages in aortic atherosclerotic lesion from apolipoprotein E-deficient mice and from human carotid artery contain lipid peroxides and oxysterolsI Maor, M Kaplan, T Hayek, et al.

Free Radical Research|September 11, 2014

Reduced glutathione increases quercetin stimulatory effects on HDL- or apoA1-mediated cholesterol efflux from J774A.1 macrophagesM Rosenblat, N Volkova, S Khatib, et al.

Journal of Cardiovascular Pharmacology|February 1, 1996

Fosinopril reduces ADP-induced platelet aggregation in hypertensive patientsS Keidar, J Oiknine, A Leiba, et al.

Atherosclerosis|May 1, 1992

The effect of probucol on HDL-mediated sterol translocation and efflux from cellsS Zambon, R Brazg, M Aviram, et al.

Journal of Cardiovascular Pharmacology|February 10, 1998

Interactions of platelets, macrophages, and lipoproteins in hypercholesterolemia: antiatherogenic effects of HMG-CoA reductase inhibitor therapyM Aviram, O Hussein, M Rosenblat, et al.

Pageof 26

Showing results (191-200 of 255) with videos related to

Sort By:

Pageof 26

Annals of Nutrition & Metabolism|September 6, 2000

Dietary supplementation of a natural isomer mixture of beta-carotene inhibits oxidation of LDL derived from patients with diabetes mellitusY Levy, H Zaltsberg, A Ben-Amotz, et al.

Metabolism: Clinical and Experimental|January 1, 1979

Low density lipoprotein metabolism in type IV and type V hyperlipoproteinemiaJ G Brook, H Torsvik, R S Lees, et al.

Scandinavian Journal of Clinical and Laboratory Investigation|November 1, 1992

Effect of lovastatin on lipoprotein fluidity in patients with hypercholesterolaemiaY Levy, L Klein, M Aviram, et al.

Atherosclerosis|April 27, 2000

Macrophage-released proteoglycans enhance LDL aggregation: studies in aorta from apolipoprotein E-deficient miceI Maor, T Hayek, M Hirsh, et al.

Atherosclerosis|May 6, 1998

The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidationP A Belinky, M Aviram, B Fuhrman, et al.

Biochemical and Biophysical Research Communications|March 18, 2000

Oxidized monocyte-derived macrophages in aortic atherosclerotic lesion from apolipoprotein E-deficient mice and from human carotid artery contain lipid peroxides and oxysterolsI Maor, M Kaplan, T Hayek, et al.

Free Radical Research|September 11, 2014

Reduced glutathione increases quercetin stimulatory effects on HDL- or apoA1-mediated cholesterol efflux from J774A.1 macrophagesM Rosenblat, N Volkova, S Khatib, et al.

Journal of Cardiovascular Pharmacology|February 1, 1996

Fosinopril reduces ADP-induced platelet aggregation in hypertensive patientsS Keidar, J Oiknine, A Leiba, et al.

Atherosclerosis|May 1, 1992

The effect of probucol on HDL-mediated sterol translocation and efflux from cellsS Zambon, R Brazg, M Aviram, et al.

Journal of Cardiovascular Pharmacology|February 10, 1998

Interactions of platelets, macrophages, and lipoproteins in hypercholesterolemia: antiatherogenic effects of HMG-CoA reductase inhibitor therapyM Aviram, O Hussein, M Rosenblat, et al.

Pageof 26